About the Hematology/Oncology Fellowship Program

Accreditation

First accredited in the 1980s, our fellowship program has received full accreditation by the Accreditation Council for Graduate Medical Education (ACGME) through 2014. The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta is affiliated with Emory University School of Medicine, which is ranked among the top research medical schools in the country by U.S.News & World Report.

Funding

There is funding for four new fellows each year to be fully supported throughout the three-year program. Additional years of research training, including application for the Masters of Science in Clinical Research (MSCR) program, are available for highly qualified candidates.

Facility Features

SR-Inpatient-UnitWith services offered at three hospitals, Egleston, Hughes Spalding and Scottish Rite, the Aflac Cancer Center features:

  • 54-bed inpatient facilities
  • 10 specially designed rooms for blood and marrow transplantation (BMT)
  • Outpatient clinics with full range of infusional services
  • Onsite diagnostics, cell processing laboratory, surgical oncology and pharmacy services
  • MIBG treatment room—we are one of only a handful of pediatrics centers in the U.S. to offer MIBG treatment

Take a photo tour of our facilities

Dual Campus Model

In 1998, Egleston Children's Health Care System and Scottish Rite Medical Center came together to form Children's Healthcare of Atlanta—one of the largest pediatric systems in the country. The merger of Egleston, the pediatric teaching affiliate of Emory University School of Medicine, and Scottish Rite, the private hospital, provides our fellows with a unique learning experience.

Our dual campus model allows fellows to interact with physicians and subspecialty colleagues in both private and academic settings affording them a real-world training experience. Additionally, our model contributes to some of the country's largest pediatric patient volumes, exposing fellows to more educational cases and greater research opportunities.

While physical locations may be different, our individual hematology/oncology inpatient and outpatient units operate under the same clinical practice standards and use the same electronic medical records allowing consistency across the two hospital campuses. Video conferencing also effectively links both campuses for meetings. Fellows will be on-service and on-call at one campus at a time to alleviate travel between campuses. 

“I was concerned about the two campus model when I interviewed, however, there are actually many benefits. In my own experience, rotating between Egleston and Scottish Rite has enhanced by fellowship experience.” -Shep Nickel, Fellow

Population Served

The following are 2012 statistics:

  • New childhood cancer cases: 370
  • Active sickle cell disease patients: 1,724
  • Hemostasis and thrombosis: 598
  • Pediatric blood and marrow transplants (BMT) cases: 58
  • Outpatient visits: 28,573
  • Inpatient days: 18,288

More volume and outcome data

Comprehensive Cancer and Blood Disorders Program

With specially designed facilities, innovative diagnostic equipment, educational programs and psychosocial support, the Aflac Cancer Center team offers comprehensive care to all our patients. We offer exceptional pediatric imaging, surgical subspecialty and subspecialty support. Our multidisciplinary approach to children's care integrates the efforts of other pediatric professionals, including:

  • Nurses
  • Pharmacists
  • Nurse practitioners
  • Nutritionist
  • Social workers
  • Child life specialists
  • Psychologists
  • Chaplains
  • Hospital teachers
  • Utilization review specialist

Specialty Services

Hematology

  • Sickle cell disease
  • Thalassemia
  • Hemophilia, thrombosis and other coagulation and blood disorders
  • Other red blood cell disorders, including acute and chronic anemias
  • White blood cell disorders
  • Bone marrow failure syndromes

Oncology

  • Leukemia and lymphoma
  • Neuroblastoma
  • Brain tumors
  • Wilms’ tumor and other kidney tumors
  • Bone and soft tissue tumors
  • Retinoblastoma
  • Rare pediatric malignancies
  • Histiocytic and lymphoproliferative disorders

Blood and Marrow Transplant  (BMT)

  • Allogeneic transplants
    • Related and unrelated donor transplants
    • Partially matched and related donor transplants
    • Umbilical cord blood transplants
  • Autologous transplants
    • Single and sequential (tandem) transplants
    • Pediatric apheresis services